Nursing Interventions of Chemotherapyinduced peripheral neuropathy and neuropathic pain in patients receiving taxanes and platino: A literature review

Yıl 2013, Cilt: 15 Sayı: 1, 61 - 73, 01.04.2013

Kübra Saklı Ayten Demir-zencirci

Öz

Peripheral neuropathy is one of the most common complications in the cancer treatment. Natural progression of chemotherapy- induced peripheral neuropathy deteriorates with repeating chemotherapy cures. Early diagnosis and treatment of neuropathy is very important for the life quality of patient receiving cancer treatment. However, data are very limited in this subject. Aim: The aim of this systematic review is to investigate the studies which evaluate peripheral neuropathy and neuropathic pain related with peripheral neuropathy, to determine possible nursing initiatives in this subject, and to provide basis for possible future studies. Method: Databases of Web of Knowledge and Pubmed are used for getting through journal articles related with the subject. In the queries, the keywords, “chemotherapy”, “peripheral neuropathy”, “pain”, “nursing”, “neuropathic pain”, “chemotherapy”, “oncology”, “peripheral neuropathy”, “chemotherapy”, “neuropathic pain”, “neuropathy”, and “nursing”, are used in different order. Seven articles related with chemotherapy induced peripheral neuropathy are gotten through. Results: The percentage of taxanes and platinos for causing peripheral neuropathy and neuropathic pain varies between 18% and 82%. As a result of the studies, chemotherapeutic peripheral neuropathy and neuropathic pain are found to be affecting the treatment period and casual life activities of the patients significantly. Conclusion: Fewness of the studies related with the subject and measurement devices makes performing new studies obligatory

Anahtar Kelimeler

“chemotherapy”, “peripheral neuropathy”, “pain”, “nursing”, “neuropathic pain”

Taksan ve Platin Alan Hastalarda Periferal Nöropati ve Nöropatik Ağrıya Yönelik Hemşirelik Girişimleri: Sistematik Derleme

Öz

Periferik nöropati kanser tedavisinin en sık görülen komplikasyonlarından biridir. Kemoterapi ilişkili periferik nöropatinin doğal seyri,tekrarlayan kemoterapi kürleri ile giderek kötüleşmektedir. Nöropatinin erken saptanması ve tedavi edilmesi, kanser tedavisi alan hastanın yaşam kalitesi için çok önemlidir. Ancak bu konuda veriler oldukça sınırlıdır. Amaç: Bu sistematik derlemenin amacı; periferal nöropati ve periferal nöropatiye ilişkin nöropatik ağrının değerlendirildiği çalışmalarınincelenmesi, bu konuda yapılabilecek hemşirelik girişimlerinin saptanması ve gelecekte yapılabilecek araştırmalara dayanak sağlanmasıdır. Yöntem: Konuyla ilgili makalelere ulaşmak için Web of Knowledge vePubmed veri tabanları kullanıldı. Taramalarda “chemotherapy”,“peripheral neuropathy”, “pain”, “nursing”, “neuropathic pain”,“chemotherapy”, “oncology”, “peripheral neuropathy”, “chemotherapy”, “neuropathic pain”, “neuropathy” ve “nursing” anahtar kelimeleri değişik sıralamalarla kullanıldı. Toplamda kemoterapi ilişkili periferal nöropati ile ilgili yedi makaleye ulaşıldı. Bulgular: Taksan ve platinin periferal nöropatiye ve nöropatik ağrıya neden olma oranları %18 ila %82 arasında değişmektedir. Çalışmalar sonucunda kemoterapötik periferal nöropati ve nöropatik ağrının hastaların tedavi sürecini ve günlük yaşam aktivitelerini önemliölçüde etkilediği bulundu.Sonuç: Konuyla ilgili çalışmaların ve ölçme araçlarının az oluşu yeni çalışmaların yapılmasını zorunlu kılmaktadır

Anahtar Kelimeler

Kemoterapi, taksanler, platin, periferal nöropatiler, ağrı, hemşirelik

Kaynakça

• American Cancer Society (internet). Cancer Basics. Available from: http://www.cancer.org /cancer/cancerbasics/what-is-cancer, (Accessed 2013 March 30)
• Tuncer MA, Özgül N, Olcayto E, Gültekin M. Kanserin Ülkemiz ve Dünyadaki Önemi, Hasta- lık Yükü ve Kanser Kontrol Politikaları. Tuncer MA. Türkiyede Kanser Kontrolü. Ankara: Koza Matbaacılık, 2009; 5.
• World Health Organization (WHO) [internet] . Pain and Palliative Care Communications Prog- ramme. Available from: http://www.whocancer- pain.wisc.edu/contents.html?q=node/312, (Ac- cessed 2013 March 30)
• Wilkes GM, Barton- Burke M. Oncology Nur- sing Drug Handbook. Burlington: Jones & Bartlett Learning, 2013.
• Partridge AH, Burstein HJ ve Winer EP. Side Effects of Chemotherapy and Combined Che- mohormonal Therapy in Women With Early- Stage Breast Cancer. J Natl Cancer Inst Mo- nogr 2001; 30: 135-42.
• Kaley TJ, DeAngelis LM. Therapy of Chemot- heraphy- Induced Peripheral Neuropathy. Br J Haematol 2009; 145: 3- 14.
• Lavoie Smith EM, Beck SL, Cohen J. The Total Neuropathy Score: A Tool for Measuring Che- motherapy- Induced Peripheral Neuropathy. Oncol Nurs Forum 2008; 35: 1.
• Perry MC, Hausheer FH. Chemotherapy Indu- ced Peripheral Neuropathy. The Chemotherapy Source Book, (4. baskı). Philadelphia: Lippin- cott Williams & Wilkins, 2008; 234- 244.
• Reyes-Gibby CC, Morrow PK, Buzdar A, She- te S. Chemotherapy-Induced Peripheral Neuro- pathy as a Predictor of Neuropathic Pain in Bre- ast Cancer Patients Previously Treated With Paclitaxel. J Pain 2009; 10: 11.
• Tofthagen C. Patient Perception Assosiated with Chemotherapy- Induced Peripheral Neuro- pathy. Clin J Oncol Nurs 2010; 14: 3.
• Lavoie Smith E, Bakitas Whedon M, Bookbin- der M. Quality Improvement of Painful Perip- heral Neuropathy. Semin Oncol Nurs 2002; 38(1): 36- 43.
• Tofthagen C, McAllister RD, McMillani SC. Peripheral Neuropathy in Patients with Colo- rectal Cancer Receiving Oxaliplatin. Clin J On- col Nurs 2011; 15: 2.
• Lavoie Smith EM, Cohen JA, Pett MA, Beck SL. The Reliability and Validity of a Modified Total Neuropathy Score- Reduced and Neuro- pathic Pain Severity Items When Used to Me- asure Chemotherapy- Induced Peripheral Ne- uropathyin Patients Receiving Taxanes and Pla- tinums. Cancer Nurs 2010; 33: 3.
• Donald GK, Tobin I, Stringer J. Evaluation of Acupuncture in the Management of Chemothe- rapy-Induced Peripheral Neuropathy. Acupunct Med 2011; 29: 3.
• Lavoie Smith EM, Cohen JA, Pett MA, Beck, SL. The Validity of Neuropathy and Neuropat- hic Pain Measures in Patients With Cancer Re- ceiving Taxanes and Platinums. Oncol Nurs Fo- rum 2011; 38: 2.
• Tofthagen C. Patient Perceptions Associated with Chemotherapy- Induced Peripheral Neuro- pathy. Clin J Oncol Nurs 2010; 14: 3.
• Tofthagen C, McMillan, SC. Pain, neuropathic symptoms, and physical and mental well- being in persons with cancer. Cancer Nurs 2010; 33: 437- 444.
• Itano JK, Taoka KN. Core Curriculum For On- cology Nursing, (4. Baskı). Philadelphia: Else- vier, 2005.
• Mahfudh, SS. Nurse’s Role in Controlling Can- cer Pain. J Pediatr Hematol Oncol 2011; 33: 146- 148.